Neuroinflammation: A Common Pathway in Alzheimer’s Disease and Epilepsy
Yee Liew(Monash University Malaysia), Mohd. Farooq Shaikh(University of Mumbai), Terence J. O’Brien(The Royal Melbourne Hospital), Nigel C. Jones(GlaxoSmithKline (United Kingdom)), Alina Arulsamy(Monash University Malaysia), Idrish Ali(The Alfred Hospital), Thaarvena Retinasamy(Monash University Malaysia)
Cited by 24
Related Papers
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
|Frontiers in Neuroscience|2018|318
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
|The American Journal of Human Genetics|2019|310
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
|Cells|2020|257
Ultra-rare genetic variation in common epilepsies: a case-control sequencing study
|The Lancet Neurology|2017|234